Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects
Author:
Affiliation:
1. MSD K.K. Tokyo Japan
2. Merck & Co., Inc. Kenilworth New Jersey USA
3. PAREXEL International Early Phase Research Physicians Glendale California USA
4. P‐One Clinic Keikokai Medical Corporation Tokyo Japan
Funder
Merck Sharp and Dohme
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.1081
Reference33 articles.
1. Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation
2. Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
3. Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
4. Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future
5. The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment;Viruses;2024-09-07
2. Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation;Clinical Pharmacokinetics;2024-07
3. Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study;Clinical and Experimental Nephrology;2024-04-13
4. A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing;Frontiers in Immunology;2024-02-01
5. Letermovir for CMV Prophylaxis in Very High-Risk Pediatric Hematopoietic Stem Cell Transplantation Recipients for Inborn Errors of Immunity;Journal of Clinical Immunology;2023-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3